Annual report pursuant to Section 13 and 15(d)

Warrants

v3.21.2
Warrants
12 Months Ended
Mar. 31, 2021
Warrants  
Warrants

10. Warrants

The following is a continuity schedule of the Company’s common share purchase warrants:

 

 

 

 

 

 

 

    

 

    

Weighted 

 

 

Number of

 

Average

 

 

Warrants

 

Exercise Price

Outstanding and exercisable, March 31, 2019

 

288,517

 

40.27

Expired

 

(163,483)

 

(38.91)

Outstanding and exercisable, March 31, 2020

 

125,034

 

20.07

Expired

 

(2,667)

 

(37.50)

Outstanding and exercisable March 31, 2021

 

122,367

 

19.69

 

During the year ended March 31, 2021 and 2020, 2,667 and 163,483 warrants, respectively, expired in accordance with their terms.

The following is a summary of common share purchase warrants outstanding as of March 31, 2021.

 

 

 

 

 

 

Exercise

    

Number of

    

 

Price ($)

 

Warrants

 

Expiry Date

90.00

 

15,658

 

March 31, 2023

9.375

 

64,025

 

August 14, 2022

9.375

 

42,684

 

March 31, 2022

 

 

122,367

 

 

 

The weighted-average remaining contractual term of the outstanding warrants was 1.32 years.